TTRX
NASDAQ · Pharmaceuticals
Turn Therapeutics Inc
$3.44
+0.02 (+0.58%)
Open$3.41
Previous Close$3.42
Day High$3.45
Day Low$3.20
52W High$26.50
52W Low$2.57
Volume—
Avg Volume18.2K
Market Cap101.00M
P/E Ratio—
EPS$-0.08
SectorPharmaceuticals
Analyst Ratings
Strong Buy
8 analysts
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 28.41M | 28.26M | 24.54M |
| Net Income | 5.07M | 4.33M | 4.07M |
| Profit Margin | 17.8% | 15.3% | 16.6% |
| EBITDA | 7.12M | 6.76M | 5.89M |
| Free Cash Flow | 5.68M | 5.26M | 4.99M |
| Rev Growth | +18.7% | -2.9% | -7.4% |
| Debt/Equity | 0.72 | 0.77 | 0.81 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $916.31 | +1.47% | 46.4 | 957.52B |
| JNJ | Johnson & Johnson | $239.93 | +1.98% | 22.2 | 594.00B |
| MRK | Merck & Co. Inc. | $119.37 | +2.58% | 16.5 | 301.17B |
| PFE | Pfizer Inc. | $27.28 | +1.19% | 19.7 | 153.36B |
| BMY | Bristol-Myers Squibb Co | $58.94 | +2.70% | 16.5 | 116.58B |
| ZTS | Zoetis Inc | $116.71 | +0.67% | 21.5 | 57.37B |